J Am Chem Soc by Cacho, Ralph A. et al.
Identification and Characterization of the Echinocandin B
Biosynthetic Gene Cluster from Emericella rugulosa NRRL
11440
Ralph A. Cacho1, Wei Jiang3, Yit-Heng Chooi1, Christopher T. Walsh3,*, and Yi Tang1,2,*
1Department of Chemical and Biomolecular Engineering, University of California, Los Angeles,
420 Westwood Plaza, Los Angeles, CA 90095
2Department of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles
E. Young Drive East, Los Angeles, CA 90095
3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 200
Longwood Ave, Boston, MA 02115
Abstract
Echinocandins are a family of fungal lipidated cyclic hexapeptide natural products. Due to their
effectiveness as antifungal agents, three semisynthetic derivatives have been developed and
approved for treatment of human invasive candidiasis. All six of the amino acid residues are
hydroxylated, including 4R,5R-dihydroxy-L-ornithine, 4R-hydroxyl-L-proline, 3S,4S-dihydroxy-
L-homotyrosine, and 3S-hydroxyl,4S-methyl-L-proline. We report here the biosynthetic gene
cluster of echinocandin B 1 from Emericella rugulosa NRRL 11440 containing genes encoding for
a six-module nonribosomal peptide synthetase EcdA, an acyl-AMP ligase EcdI and oxygenases
EcdG, EcdH and EcdK. We showed EcdI activates linoleate as linoleyl-AMP and installs it on the
first thiolation domain of EcdA. We have also established through ATP:PPi exchange assay that
EcdA loads L-ornithine in the first module. A separate hty gene cluster encodes four enzymes for
de novo generation of L-homotyrosine from acetyl-CoA and 4-hydroxy-phenyl-pyruvate is found
from the sequenced genome. Deletions in the ecdA, and htyA genes validate their essential roles in
echinocandin B production. Five predicted iron-centered oxygenase genes, ecdG, ecdH, ecdK,
htyE, htyF, in the two separate ecd and hty clusters are likely to be the tailoring oxygenases for
maturation of the nascent NRPS lipohexapeptidolactam product.
Keywords
antifungal; nonribosomal peptide; lipopeptide; unnatural amino acids; genome mining
INTRODUCTION
Invasive candidiasis caused by opportunistic pathogenic strains of genus Candida, accounts
for 17% of ICU-related infections, third highest after Staphylococcus aureus and
Pseudomonas spp.-related infections.1 Moreover, there has been a steady increase in the
incidence of invasive candidiasis correlating with the increased use of immunosuppressants,
broad-spectrum antibiotics, intravenous catheters and prosthetics and invasive clinical
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procedures.2–3 Echinocandins, a family of lipohexapeptides that prevent fungal wall
synthesis through noncompetitive inhibition of 1,3-β-glucan synthase, rapidly rose to the top
ranks of antifungal agents due to their activity against a wide range of Candida spp., in
particular azole-resistant strains, and are significantly less toxic compared to Amphotericin
B.4–5
As the first echinocandin discovered, Echinocandin B 1, was isolated from Aspergillus
nidulans var. echinulatus6 and A. nidulans var. roseus NRRL 11440.7 While 1 and family
members subsequently isolated, such as pneumocandin A0 4,8 aculeacin,9 cryptocandin,10
and mulundocandin11, show anti-Candida activity, the hemolytic properties of natural
echinocandins prevented their use as therapeutics. Derivatization of 1 and 4, especially in
the fatty acid moiety, led to the development of cilofungin 2,12–13 anidulafungin 3 (Eraxis,
Pfizer), 14 caspofungin (Cancidas, Merck and Co) 5,15 and micafungin 6 (Mycamine,
Astellas Pharma)16 (Scheme 1) that have less hemolytic properties while retaining the
bioactivity of their parent compound. For example, 3, a semisynthetic derivative of 1
containing a substituted terphenyl acyl chain, was approved by the FDA in 2006.14,17
In addition to their antifungal activity, echinocandins reflect interesting biosynthetic features
in their structures. Aside from the long chain fatty acyl amide, the presence of
nonproteinogenic amino acids 4R, 5R-dihydroxyl-L-ornithine, 3S-hydroxyl,4S-methyl-L-
proline, 4R-hydroxyl-L-proline and 3S, 4S-dihydroxyl-L-homotyrosine suggests
echinocandins are synthesized by nonribosomal peptide synthetases (NRPSs). An intriguing
feature of echinocandins is the presence of multiple alcohol and diol groups within the
scaffold as a result of the incorporation of these unnatural residues; most distinct of these
hydroxyl groups are at Cδ of L-ornithine which creates a hydrolytically labile hemiaminal in
the macrocycle18–19 and the vicinal diol found in 3S,4S-dihydroxy-L-homotyrosine. It is
noted that enzymatic Cδ-hydroxylation of L-ornithine is a particularly novel and challenging
reaction due to the presence of the neighboring amine. Because of this unstable linkage, the
total synthesis of 1 has not been demonstrated so far. Only simpler versions without the
hydroxyl groups in the L-ornithine position, such as echinocandin D, have been synthesized
and used in SAR studies.20–22
Despite the medical importance and intriguing structural motifs in echinocandin, the genetic
and molecular basis for the biosynthesis of this family has remained unknown to date. The
enzymology (sequence, specificity, type of oxygenase) behind this multitude of
hydroxylation steps is also unresolved. A. nidulans var. roseus NRRL 11440 (ATCC 58397)
is an industrially important strain that produces 1, which is a precursor for the semisynthetic
3 (Scheme 1). A polyphasic characterization showed that this strain should belong to the
Emericella rugulosa species and henceforth, we use that nomenclature here.23 In this study,
we report the discovery of the gene cluster of 1 in this strain through gene deletion of a
multimodular NRPS and biochemical characterization of the enzymes involved in the lipo-
initiation process. Through gene deletion and chemical complementation, we have also
uncovered the separate gene cluster responsible for the biosynthesis of L-homotyrosine in
the peptide scaffold of 1.
RESULTS
Whole Genome Sequencing and Analysis of NRPS Gene Clusters of Emericella rugulosa
NRRL 11440
Whole genome shotgun sequencing of E. rugulosa NRRL 11440 was performed using
Illumina HiSeq2000 to generate ~17 Gbp of sequence. Assembly of the sequence reads
generated 433 contigs with N50 length of 235,313 bases (See Table S1). The total length of
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the 433 contigs amounts to 32,224,016 bases, which is slightly larger than the genome size
of the previously sequenced A. nidulans A4 strain of ~31 Mb.24
Using the first adenylation (A) domain of the enzyme TqaA (accession number:
ADY16697) from the tryptoquialanine pathway25 as BLAST query, we were able to find 26
putative NRPS genes in E. rugulosa (Table S2). Four out of the twenty-six NRPSs, which
we denoted as ErNRPSs, are NRPSs with five or more modules. Two of these four
ErNRPSs, annotated as ErNRPS99 and ErNRPS57, are also found in the model fungi A.
nidulans A4 that does not produce 1. ErNRPS99 is likely a homolog of EasA found in the
biosynthesis of emericellamide26 due to the high shared sequence identity between the two.
ErNRPS57, on the other hand, contains a terminal reductive domain (R) similar to what is
found in peptaibol synthetases.27 Thus, this leaves ErNRPS284 and ErNRPS123 as
echinocandin synthetase candidates. ErNRPS284 (Table S2) contains five modules, which
are insufficient for catalyzing the formation of the hexalipopeptide scaffold of 1 based on
the colinearity hypothesis.28 On the other hand, the six-module ErNRPS123 (799 kDa),
which is annotated as ecdA, has the correct number of modules necessary for the assembly
of 1. However, performing A domain selectivity prediction using NRPS predictor29 offered
little confirmation that this is the correct echinocandin NRPS, with only the third A domain
prediction (L-proline) matching the corresponding amino acid in 1 (L-proline or 4R-
hydroxyl-L-proline) (Table S3). Further bioinformatics analysis of the domain architecture
of EcdA, as well as the genes within the ecd cluster, gave indications that this is most likely
the correct gene cluster that is consistent with some of the expected biosynthetic
transformations required for the assembly of 1. First, EcdA has a terminal condensation
domain (CT) that has been shown to catalyze the cyclization of NRPS products in fungi30, in
agreement with the anticipated macrocyclization of the hexapeptide. Furthermore, in
proximity to ecdA is ecdI (Figure 1A and Table 1), an acyl-AMP ligase homolog gene,
giving a plausible route for lipo-initiation of the NRPS. In addition, other genes adjacent to
ecdA encode putative non-heme iron, α-ketoglutaratedependent oxygenases (ecdG and
ecdK), and a cytochrome P450 heme-iron-dependent oxygenase (ecdH) (Table 1), indicating
that the nascent NRPS product may undergo several oxygenation steps, as anticipated for the
biosynthesis of 1. Other genes flanking the putative ecd cluster encode a fungal transcription
factor gene (ecdB), three transporter protein genes (ecdC, ecdD and ecdL), a glycosyl
hydrolase gene (ecdE), a glycosidase gene (ecdF) and a gene encoding for a protein with no
predicted conserved domain (ecdJ). Interestingly, genes encoding the biosynthesis of
unnatural amino acids such as L-homotyrosine are not present in the vicinity of ecd gene
cluster, but are found to reside elsewhere on the genome (see below).
Verification of the role of ecdA in the biosynthesis of 1
To confirm the production of 1, E. rugulosa was grown in Medium 2 and the metabolite
extracted from the fermentation broth in the same manner as previously described.7 High
resolution LCMS trace of the extracted metabolites shows a peak at 17.6 min with m/z of
1042.5700 [M+H-H2O]+ corresponding to the theoretical mass-to charge ratio of 1 (m/z
=1042.5707 [C52H81N7O16+H-H2O]+) (Figure 1B). Purification and subsequent
characterization by NMR (Table S3 and Figure S13–S16) and comparison with authentic
standard (Figure S1) verified that the compound is indeed 1.
To verify whether the ecd cluster is responsible for the production of 1, we developed a gene
deletion method for E. rugulosa based on previous methods for A. nidulans A4,31 using the
glufosinate resistance gene bar as selection marker (See Materials and Methods).32 A gene
deletion cassette containing portions of ecdA internally disrupted by the bar gene driven by
the trpC promoter was introduced into E. rugulosa protoplasts via PEG-mediated
transformation and the resulting glufosinate-resistant strains were selected. A bioassay-
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guided knockout screening was developed in which individual fungal colonies are spotted
on plates pre-inoculated with C. albicans. Approximately 100 mutants were screened by
both loss of anti-Candida activity, and PCR-based screening using a bar gene primer and a
primer found outside the knockout cassette. One mutant (ΔecdA I-16) was isolated which
lost the ability to inhibit the growth of C. albicans (Figure S2) and also showed the correct
PCR-amplified product (Figure S3). LCMS analysis of the extracted metabolites after 7 days
of growth showed no production of 1 (Figure 1B), suggesting that EcdA is the NRPS
responsible for the biosynthesis of 1.
Characterization of the Adenylation domain (A) of the First Module of EcdA
Guided by the results of the gene knockout of ecdA, we proceeded to determine the amino
acid specificity of the first A domain of EcdA by cloning the initiation module of EcdA,
which is fused to a thiolation domain (T0) that is likely the site of lipid attachment (EcdA-
M1, T0CAT1). The 130 kDa protein was expressed in Escherichia coli BL21(DE3) cells to a
final titer of ~20 mg/L and purity of >95% (Figure S4). Amino acid-dependent ATP-[32P]-
PPi exchange assay with 2 μM of EcdA-M1 at ambient temperature and incubation time of
30 minutes showed that A1 could activate L-ornithine (L-Orn) and (4R/S)-4-hydroxyl-L-
ornithine (4- OH-L-Orn). D-ornithine and other amino acids with basic side chains such as
L-lysine and L-arginine were not activated (Figure 2A). Full kinetic analysis shows that L-
Orn (kcat= 43.5 ± 1.9 min−1, KM= 45.4 ± 8.8 μM) is about a 500-fold better substrate than 4-
OH-L-Orn (kcat= 5.6 ± 0.2 min−1, KM= 2.7 ± 0.3 mM) as judged by kcat/KM ratios (Figure
2B and 2C), suggesting that oxidation at Cγ of L-ornithine most likely occurs after loading
of L-Orn to T1. The activation of L-Orn by the first module of EcdA further supports the
link between the NRPS and the biosynthesis of 1.
EcdI catalyzed Lipo-initiation of EcdA
The addition of the lipid chain in the biosynthesis of lipopeptides, also known as lipo-
initiation33–34, is a critical step not only because it connects the fatty acid pool and NRPS
biosynthesis, but also due to the importance of the lipid to the antimicrobial activities. 14
Several mechanisms exist in activating and transferring the lipid chain to the NRPS.34 These
include fusion of a fatty acid synthetase (FAS)-like module to the N-terminus of a NRPS
(mycosubtilin)35; and transfer of the lipid chain to a dissociated T domain (daptomycin)36–37
or coenzyme A (surfactin) 33 by a fatty acyl ligase, followed by condensation with an
aminoacyl adenylate catalyzed by the first C domain. Since EcdA only contains six A
domains, one for each of the residues in the hexapeptide scaffold, we reasoned that EcdI,
containing an AMP-binding domain might be responsible for the formation of the activated
form of linoleic acid and its transfer to the T0 domain of EcdA. To test this hypothesis, we
cloned EcdI Into an E. coli expression vector and expressed the N-terminal His-tagged
protein in BL21(DE3) with a titer of ~30mg/L and purity of ~95% (Figure S5). Using the
purified phosphopantetheinyl transferase Sfp from Bacillus subtilis, 38 we converted apo
EcdA-M1 into its holo form in vitro. After co-incubation of holo EcdA-M1 with EcdI, ATP
and [14C]-linoleic acid, the assay mixture was analyzed using SDS-PAGE and
autoradiography. The autoradiogram shows a strong radiolabeling of the 130 kDa band,
indicating that the 14C-linoleic acid is covalently bound to EcdA-M1 (Figure 3A). In
contrast, in the absence of EcdI, ATP or Sfp, nearly no labeling of EcdA-M1 can be
detected, confirming the proposed mechanism (Figure 3C). Quantification of the radiolabel
suggests that ~30% of EcdA-M1 is loaded with the labeled substrate (Figure 3B), consistent
with fractional stoichiometries seen in other labeling studies.39–40
To pinpoint which of the two thiolation domains in EcdA initiation module (T0CAT1) is
acylated by the linoleoyl starter unit in the presence of EcdI, single mutations to the active
site serines in the two thiolation domains were made. The S47A mutant (T0*CAT1) prevents
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phosphopantetheinylation of the initiation T domain, but leaves the T1 domain available for
conversion into the holo form that should be capable of undergoing covalent loading with
[14C]-L-ornithine. Conversely, the corresponding S1127A mutant (T0CAT1*) will not be
phosphopantetheinylated at T1 but should be able to load [14C]-linoleate. Both the S47A and
the S1127A mutants were expressed from E.coli BAP1,41 which coexpresses Sfp for
thiolation domain phosphopantetheinylation (thus no Sfp preincubation is required) (Figure
S6). As shown in Figure S7, [14C]-linoleate is loaded onto the T0CAT1* but not the
T0*CAT1 variant of the EcdA initiation module, as assessed by both autoradiography and by
radioactive counting of protein precipitated via addition of trichloroacetic acid. The
complementary result is seen for [14C]-L-ornithine covalent loading in which T0*CAT is
labeled but T0CAT1* is not (Figure S8). The relatively low amount of L-Orn radioactivity
may reflect lability of the thioester due to the attack by the Nγ of the ornithine side chain to
the activated carbonyl carbon followed by the subsequent release of the cyclic δ-lactam, a
known propensity of ornithine thioesters.42
In previously characterized lipopeptide NRPSs, the incorporation of fatty acids into the
assembly line requires the formation of either acyl-CoA33 or acyl-AMP36 prior to loading
onto the NRPS. To explore the mechanism of linoleic acid activation by EcdI, we removed
excess CoA after conversion of apo EcdA-M1 to its holo form, followed by addition of 0,
0.5 or 5.0 mM CoA to the assay. The reaction rates for the acyl loading step, as determined
by the fraction of EcdA-M1 loaded with labeled substrate at different time points, are
essentially the same (Figure S9), ruling out the CoA-dependent mechanism and indicating
that the acyl-AMP is directly transferred to EcdA-T0 by EcdI (Figure 3C).
In order to probe the substrate specificity of EcdI, we coincubated holo-EcdA-M1 with
alternative acyl substrates. Palmitic acid (C-16) showed similar degree of loading to EcdA-
M1 compared to linoleic acid (27% vs. 30 % for linoleic acid). Decreasing the length of the
acyl chain to C-10 ([14C]-decanoic acid), on the other hand, dramatically reduced the
loading of EcdA to ~8% at time points where the loading of linoleic acid reaches saturation.
Nevertheless, this range of fatty acyl chain lengths that can be transferred to EcdA-M1
indicates there is room for incorporation of alternative lipid starter molecules into the
structure of 1. Incubation of EcdI and EcdA-M1 with non-fatty-acid substrate such as
benzoic acid, an aryl carboxylate, did not show covalent loading onto T0 (Figure S10).
Discovery of the L-homotyrosine biosynthetic gene cluster
One of the characteristic features of the echinocandin family is the presence of
nonproteinogenic 3S, 4S-dihydroxyl-L-homotyrosine in the 4th amino acid position of the
cyclic hexapeptide. This residue is derived from the dihydroxylation of L-homotyrosine
either prior to, or after incorporation into the peptide scaffold. It was previously shown that
Lhomotyrosine in the scaffold of 4 is derived from the condensation of 4-hydroxyphenyl-
pyruvate and acetate to form 2-(4- hydroxybenzyl)-malate.43 Likewise, the biosynthesis of
L-homophenylalanine in watercress plants is proposed to follow a pathway analogous to
leucine biosynthesis,44 beginning with the condensation of acetyl-CoA and phenylpyruvate
to form benzylmalic acid. In order to find putative 2-(4- hydroxybenzyl)-malate synthase
(HBMS) that may be involved in L-homotyrosine biogenesis, we searched the E. rugulosa
genome for genes encoding the functionally analogous isopropyl-malate synthase (IPMS),
the enzyme that catalyzes the condensation of α-ketovalerate with acetyl-CoA in leucine
biosynthesis. We used the IPMS gene from Mycobacterium tuberculosis (accession number:
MT3813) as BLAST query. Two significant hits were found, ErIPMS48 and ErIPMS66,
both of which are found outside the contig containing the ecd gene cluster. ErIPMS48 shares
99% protein sequence identity to the predicted A. nidulans A4 housekeeping IPMS
(AN0804) as well as >85% identity to predicted IPMS in other ascomycetes, suggesting that
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this gene encodes for the actual IPMS involved in leucine biosynthesis in E. rugulosa. On
the other hand, the ErIPMS66 protein sequence has a lower similarity to AN0804 (43%
protein identity), while such a second IPMS homolog is not present in A. nidulans A4.
Downstream of ErIPMS66 (designated as htyA) are genes putatively encoding a
transaminase (htyB), a 3-isopropyl-malate dehydrogenase homolog (htyC), and an
isopropyl-malate isomerase homolog (htyD), all possibly involved in biosynthesis of
Lhomotyrosine(Table 2 and Figure 4A). Moreover, the presence of immediately upstream
genes encoding for a predicted nonheme iron, α-ketoglutarate-dependent oxygenase (htyE)
and cytochrome P450 oxygenase (htyF) are consistent with the requirement of Cγ and Cδ
hydroxylation of L-homotyrosine in 1. Thus, we reasoned that the gene cluster, here
designated as hty, may be responsible for the biosynthesis of L-homotyrosine in E. rugulosa.
To confirm this hypothesis, we genetically disrupted the htyA gene in the same manner as
for construction of ΔecdA. Screening of ~100 colonies yielded 3 PCR-positive mutants
(Figure S11). All three ΔhtyA mutants lost the ability to inhibit the growth of C. albicans
under screening conditions (Figure S2), accompanied by the loss of production of 1 (Figure
4B). To chemically complement the ΔhtyA mutant, 0.1 mg/mL of L-homotyrosine were
supplemented to the growth media. As expected, adding free homotyrosine restored the
ability of the mutant to inhibit Candida (Figure S2), as well as the production of 1 (Figure
4B) to wild type levels. As a negative control, feeding of L-homotyrosine to ΔecdA I-16
mutant did not restore the production of 1 (Figure S1). Therefore, based on whole genome
sequencing, we were able to identify a separately located gene cluster that is responsible for
the biosynthesis of an unnatural amino acid building block for the ecd pathway.
Based on the putative functions of of HtyA-D (Table 2), the biosynthesis of L-homotyrosine
is predicted to be as follows (Figure 4C): 4-hydroxy-phenylpyruvate undergoes an aldol-
type condensation by HtyA with the C-2 of acetyl-CoA followed by the release of CoA to
form 2-(4-hydroxybenzyl)- malate. This is followed by isomerization of 2-(4-
hydroxybenzyl)- malate to 3-(4-hydroxybenzyl)-malate by HtyD. Thereafter, 3-(4-
hydroxybenzyl)-malate undergoes decarboxylation and oxidation to form 2-oxo-4-(4-
hydroxybenzyl)- butanoic acid, coupled to reduction of NAD+ to NADH by HtyC. The
product then undergoes transamination catalyzed by HtyB to form L-homotyrosine. The
closest homologs of HtyA-D is found in a four gene cassette from Alternaria alternata that is
predicted to catalyze the formation of 2-amino-4- phenyl-valeric acid (APVA) in AM-
toxin.45 Interestingly, this suggests that the HtyA-D homologs in the AM-toxin gene cluster
must perform two cycles of the α-ketoacid elongation to afford APVA.
DISCUSSION
Echinocandins are a family of antifungal cyclic lipopeptides from ascomycetes. Through the
sequencing of the genome of E. rugulosa NRRL 11440 and subsequent bioinformatics
analysis of NRPS genes, we have identified ecdA, encoding a 799 kDa six module NRPS,
which is confirmed by gene deletion to be required for production of 1. The ecd gene cluster
is flanked by two microsyntenic blocks belonging to two different chromosomes in A.
nidulans A4. Upstream of the ecd cluster are a group of genes that are syntenic to genes
found in Chromosome VII of A. nidulans A4 while the genes found downstream of the
cluster is syntenic to genes found in A. nidulans A4 Chromosome V (Figure S12). This
suggests that a chromosomal translocation occurred when E. rugulosa NRRL 11440 and A.
nidulans A4 diverged from their common ancestor.
Another interesting result revealed by the study is the separation of the ecd gene cluster and
the L-homotyrosine biosynthetic genes. By adding the distance to the nearest end of their
respective contigs, the minimum distance between the two clusters is ~42.5 kb, assuming
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that both clusters are located in the same chromosome (Figure S12). Moreover, similar to
the phenomenon seen in the ecd gene cluster, the hty gene cluster is flanked by
microsyntenic blocks from two different A. nidulans A4 chromosomes; upstream of hty
cluster are genes that are syntenic to genes from Chromosome VII of A. nidulans A4 while
downstream are genes that are syntenic to genes found in the A. nidulans A4 Chromosome
VI (Figure S12). This chromosomal translocation in the E. rugulosa genome, in comparison
to A. nidulans A4 genome, also prevents us from mapping the hty and ecd gene cluster in
relation to the A. nidulans A4 chromosomes. While separation of the biosynthetic genes for
1 is unusual, it is not unprecedented. Examples of the separation of secondary metabolite
biosynthetic genes in fungi are found in the dothistromin pathway in Dothistroma
septosporum46, the convergence of the orsellinic acid and anthrone biosynthetic pathways in
A. nidulans to form spiroanthrones,47 the austinol and dehydroaustinol pathways in
A.nidulans,48 and the putative tryptoquivaline pathway in A. clavatus, which is a feature
identified after comparison to the closely related tryptoquialanine pathway in Penicillium
aethiopicum.25
Due to the size of the full-length EcdA, which is a formidable challenge for in vitro
evaluation, we dissected the EcdA initiation module to establish the predicted specificity for
L-ornithine activation by A1. The ~130 kDa, four domain (T0CAT1) EcdA initiation module
(EcdA-M1) was expressed from E. coli. Determination of selectivity of A1 by amino
aciddependent ATP-[32P]-PPi exchange assay established L-ornithine as the most likely
substrate. Heterologous expression of EcdA-M1 and EcdI, an acyl-AMP ligase homolog,
allowed us to investigate the mechanism of lipo-initiation of EcdA. Co-incubation of EcdA-
M1 with EcdI, ATP and [14C]-linoleic acid indicated loading of linoleic acid to the initiation
T0 domain of EcdA. While much is known regarding the lipoinitiation strategies of the
bacterial NRPS’s,33–37 this study presents the first in vitro characterization of the lipo-
initiation of fungal NRPS. In comparison to the bacterial NRPS systems, EcdI acts
analogously to DptE in daptomycin biosynthesis: 36 each adenylates the fatty acid substrate
which is subsequently transferred to the initiation T0 domain. The difference between the
two systems is that the acceptor thiolation domain is standalone to the NRPS DptA in
daptomycin biosynthesis but is fused at the N-terminal of EcdA for the biosynthesis of 1.
Hence it is expected that the smaller EcdI requires interaction with a thiolation domain that
is part of a multimodular megasynthetases. This appears to be a commonly employed
strategy among fungal PKSs and NRPSs, in which smaller enzyme partners are recruited to
interact with the thiolation and acyl carrier protein domains.49–50 Currently, semisynthesis
of echinocandins used for medical use such as 3 and 6 require the biological deacylation of
their parent compound via feeding to separate cultures of Actinoplanes spp. followed by
chemical reacylation using protective chemistry.12,14 Thus, deciphering the lipo-initiation
strategy may also enable the engineered biosynthesis of approved derivatives of 1 containing
alternative lipid groups.
The presence of acyl-AMP ligase homolog gene ecdI within the ecd gene cluster led us to
investigate whether other organisms, in particular filamentous fungi, also have clustering of
genes encoding an acyl-AMP ligase and an NRPS with an N-terminal T0 domain. A search
in the NCBI database revealed five genes for fatty-acyl-AMP ligase that share identity ≥39%
with EcdI and are clustered with genes of NRPS with an initiation T0 domain (Table S6).
Moreover, four of the five EcdI homolog genes are also clustered with highly-reducing PKS
genes in addition to NRPS genes, further hinting that these gene clusters may encode for
lipopeptide biosynthetic enzymes. Furthermore, easD from A. nidulans, the only
characterized out of the five fatty acyl-CoA ligase genes, is shown to be involved in the
biosynthesis of emericellamide. The emericellamide synthetase EasA, however, requires an
additional acyltransferase EasC for lipo-initiation.26 Such an acyl-transferase is notably
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missing in the ecd gene cluster and is now proven not to be required for the linoleic acid
loading in our in vitro assays.
Based on the results of the lipo-initiation by EcdI and determination of the selectivity of A1,
we can propose one possible pathway for the biosynthesis of 1 (Scheme 2): linoleoyl-AMP,
produced by EcdI, is transferred to the initiation T0 of EcdA. The linoleoyl-S-
phosphopantetheinyl-T0 is sequentially extended with L-ornithine, L-threonine, L-proline,
L-homotyrosine, L-threonine and 4S-methyl-L-proline to form the linear hexapeptide.
Thereafter, the terminal condensation (CT) performs macrocyclization of the NRPS
product30 and the cyclic scaffold 7 is released from EcdA. In this pathway, in which all the
hydroxylation reactions are proposed to occur following completion of the cyclic peptide,
the unhydroxylated precursor 7 will undergo six rounds of hydroxylation. In congruence to
modification of the residues found in 1, five hydroxylase genes (ecdG, ecdH, ecdK, htyE
and htyF) are embedded within the ecd and hty clusters. At this point, it is not possible to
assign the hydroxylases based on sequence alone, as all are proposed to act on sp3
hybridized carbon atoms. It was previously shown that L-proline hydroxylation to 4R-
hydroxyl-L-proline in protein scaffolds is catalyzed by an non-heme iron, α-ketoglutarate
dependent oxygenase.51 Thus it is likely that the hydroxylation of L-proline in 1 might be
catalyzed by any of EcdG, EcdK or HtyE. However, the possibility that a P450 oxidase such
as EcdH or HtyF can catalyze the reaction cannot be excluded. On the other hand, the
formation of vicinal diols to give the 4R,5R-dihydroxyl-L-ornithine and 3S,4S-dihydroxyl-
L-homotyrosine residue are more novel compared to that of the modified proline, and may
each require two hydroxylases to separately install the two hydroxyl groups. Due to the
lability of the resulting hemiaminal,18 we anticipate that Cδ hydroxyl group in L-ornithine
must be installed after peptide macrocycle formation, and is likely the last step in the
oxidative tailoring cascade. An equally likely pathway to 1 is that some of the amino acids
are hydroxylated prior to incorporation into the hexapeptide. The most plausible candidate
for this scenario is 4R-hydroxyl-L-proline, which is a commonly observed unnatural amino
acid in different organisms52–54. The exact timing and substrate of this plethora of
hydroxylation enzymes will be determined in subsequent efforts through a combination of A
domain activation assays, genetic knockouts of the candidate oxygenases and in vitro
biochemical investigation
In addition to L-homotyrosine and L-ornithine, 1 contains the nonproteinogenic amino acid
3S-hydroxyl-4S-methyl-Lproline, which is presumably derived from 4S-methyl-Lproline.
Previous studies of 4,43 nostopeptolide,55 and nostocyclopeptide 56 biosyntheses showed
that that 4-methyl-L-proline originates from Cγ oxidation and subsequent cyclization of
Lleucine. Oxidation of L-leucine to 5-hydroxyl-L-leucine was recently identified to be
catalyzed by a non-heme iron, α-ketoglutarate dependent oxygenase in Nostoc
punctiforme.57 Thus, it is probable that one of the non-heme, α-ketoglutarate dependent
oxygenase such as EcdG, EcdK and HtyE can perform this reaction. However, both the ecd
and hty clusters do not harbor the genes encoding enzymes involved in the reactions
downstream to oxidation of L-leucine. A genome-wide search for genes for pyrroline-5-
carboxylate (P5C) reductase homolog, proposed to catalyze the final step of 4-methyl-
Lproline biosynthesis,55 revealed the presence of four candidate genes in E. rugulosa.
However, an ortholog for each of the four candidate genes are also present in A. nidulans A4
(Table S5) so at present it is not yet clear which, if any, is involved in synthesis of the 4S-
methyl-L-proline for 1.
In conclusion, we report the discovery of the biosynthetic gene cluster of 1, the first such
cluster for a member of the medically relevant fungal lipopeptide family of compounds. This
study has also uncovered the genetic basis for the biosynthesis of the nonproteinogenic L-
homotyrosine. The mechanism and timing of the hydroxylation of the residues
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Lhomotyrosine, L-proline, 4S-methyl-L-proline and L-ornithine, are intriguing features of
the biosynthesis of 1 and are currently under investigation in our groups.
MATERIALS AND METHODS
General Methods and Material
E. rugulosa (A. nidulans var. roseus) strain NRRL 11440 was obtained from Agricultural
Research Services Culture Collection (Peoria, Il). Authentic standard for 1 was purchased
from Santa Cruz Biotechnology, Inc (Santa Cruz, CA). Primers used in this study were
ordered from Integrated DNA Technologies and are listed in Table S7. Sequencing of
heterologous expression constructs and knockout cassettes was performed by Laragen, Inc
(Culver City, CA). RNA for cDNA amplification was isolated using RiboPure-Yeast Kit
from Ambion. First strand cDNA synthesis was performed using SuperScript III- First
Strand Synthesis SuperMix (Invitrogen Corp.).
Illumina Hiseq2000 Sequencing and Bioinformatic Analysis
The genomic DNA for sequencing was isolated as described elsewhere from stationary
liquid cultures.58 Shotgun sequencing was performed at Ambry Genetics (Aliso, Viejo, CA)
using Illumina Hiseq 2000 with a read size of 157 bases resulting in a total of ~17 Gbp
reads. The Illumina sequencing reads were assembled using a hierarchical assembly method
using the assembly programs SOAPdeNOVO59 and Geneious™ and performed by the
UCLA Hoffman Cluster. First, the ~17 Gbp total reads were assembled using
SOAPdeNOVO using k-mer size of 87 bp. The first-tier contigs were then assembled using
Geneious to generate 433 second tier contigs with a N50 of 235,313 and total length of ~32
Mb.
The second-tier contigs were converted to BLAST database format for local BLAST search
using stand-alone BLAST software (v. 2.2.18). Gene predictions were performed using the
FGENESH program (Softberry) and manually checked by comparing with homologous
gene/proteins in the GenBank database. Functional domains in the translated protein
sequences were predicted using Conserved Domain Search (NCBI) or InterproScan (EBI).
The nucleotide sequences for the ecd and hty gene clusters are deposited to Genbank
database with accession numbers JX421685 and JX421684, respectively.
Fungal Transformation and Gene Disruption
Polyethylene glycol-mediated transformation of E. rugulosa NRRL 11440 was performed as
done previously31 with the following modifications: the spores from two plates were grown
in 250 mL GMM with 10 mM ammonium tartrate as sole nitrogen source for 16 hrs at 250
rpm, 28°C and 1 g of the germlings from the culture was used for digestion using 3 g of
Vinotaste Pro enzyme mixture (Novozyme). The glufosinate resistance gene bar with an
upstream trpC promoter was amplified from pBARGPE1 plasmid obtained from the Fungal
Genetic Stock Center (Kansas City, MO). Glufosinate used for the selection of
transformants was prepared by extracting twice with equal volume of 1-butanol from
commercial herbicide Finale(Bayer), which contains 11.33% (w/v) glufosinate-
ammonium. 60 Construction of the knockout cassette was performed by fusion PCR as
described elsewhere.25 Fungal genomic DNA from the transformants was isolated using ZR-
Fungal/Bacterial DNA Miniprep Kit (Zymo). Primers used for PCR screening are listed in
Table S7.
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Extraction and Characterization of 1
The echinocandin extraction method is based on US Patent #4,288,549.7 Briefly, the strain
was grown in Medium 2 [2.5% (w/v) glucose (Sigma), 1% peptone (BD Biosciences), 1%
(w/v) starch (Sigma), 1%(w/v) molasses, 0.4% (w/v) N-Z Amine A (Sheffield Biosciences),
0.2% (w/v) calcium carbonate (Sigma)] in 28°C for 7 days in 10 mL cultures for screening
of transformants and 2 L for large scale compound extraction. An equal volume of methanol
was added to the whole fermentation broth and the mixture was shaken at 16°C for 1 hour.
The mixture was then filtered and the pH adjusted to 4.0. The filtrate was extracted twice
with equal volumes of chloroform. The concentrated extract was purified using Sephadex
LH-20 resin using 1:1 methanol and chloroform solvent system. The fractions containing 1,
determined by LCMS, was further purified using HPLC with C-18 column and a 40– 95%,
20 minute water:acetonitrile gradient. Purified 1 was further characterized via Agilent 6520
high-resolution QTOF/LC-MS and its 1D-1H NMR, 2D-COSY, HSQC and HMBC spectra
were recorded using a Varian 600 MHz NMR spectrometer.
Anti-Candida Assay
ΔecdA and ΔhtyA mutants were grown in 10 mL of liquid Medium 2 at static conditions for
7 days at 28°C. Discs of 10 mm in diameter were cut from the fungal mat and transferred to
yeast extract-peptone-dextrose (YPD) agar plates that were previously inoculated with
Candida albicans ATCC 90234. The co-cultures were grown at 28°C overnight. For
chemical complementation of ΔhtyA (Figure S1), L-homotyrosine (0.1 mg/mL) was fed to
the static liquid cultures at day-4 before transferring the mycelial discs from individual
clones to the YPD plate pre-inoculated with C. albicans at day-7.
Cloning of EcdA-M1
The C-terminal boundary of EcdA- T1 was predicted through alignment of gramicidin
synthetase PCP (accession: 1DNY) and fungal NRPSs with EcdA by ClustalW. EcdA-M1
was amplified from E.rugulosa cDNA sample using the primer pair NdeI-EcdA-T0 and
EcoRI-EcdA-T1 (See Table S7). The amplicon was gel-purified, digested with NdeI and
EcoRI and ligated into pET28a expression vector to create pET28a-EcdA-M1. QuikChange
I Site-Directed Mutagenesis Kit (Agilent Technologies) was used to clone the EcdA-M1
variants using pET28A-EcdA-M1 as template and ecdA-S47A-F and ecdA-S47A-R as
primer pair to create S47A variant and ecdA-S1127A-F and ecdA-S1127A-R primer pair to
create S1127A variant.
Cloning of EcdI
EcdI cDNA was amplified from E. rugulosa cDNA sample using primers EcdI-NdeI-F and
EcdI-EcoRI- R. The amplicon was ligated into PCR-blunt vector and was transformed into
TOP10 cells. The plasmid was sequenced to confirm correct splicing of the transcript. The
plasmid bearing the correct sequence was digested with NdeI and EcoRI and the insert was
cloned into pET28a vector to create pET28a-EcdI.
Heterologous expression of EcdA-M1 and EcdI
pET28a-EcdA-M1 or pET28a-EcdI was transformed into BL21 (DE3) and the cells were
grown in 500 mL LB at 37°C and 250 rpm. When the OD600 reading reached 0.4, the
cultures were cooled to 16°C and protein expression was induced by addition of 60 μM
IPTG. After 16 hr of shaking at 16°C, the cells were pelleted and resuspended in Buffer A
(50 mM Tris-HCl, pH 7.9, 5 mM NaCl, 1 mM DTT) with 20 mM imidazole. The cells were
lysed via sonication and centrifuged at 4°C at 15000 rpm. Nickel-NTA resin was added to
the supernatant and was gently stirred at 4°C for 2 hours. The protein/resin mixture was
loaded into a gravity flow column and the His-tagged proteins were purified with increasing
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concentration of imidazole in Buffer A. Additional anion exchange column purification for
EcdI in was performed using a 80 minute gradient of 0–100% Buffer A and Buffer B (50
mM Tris-HCl, 1 M NaCl, 2mM DTT) using a MonoQ 10/100L Anion exchange column
(GE Healthcare Life Sciences). The fractions containing the desired protein were
concentrated using ultrafiltration column (100 kDa cutoff, for EcdA-M1 and 30 kDa cutoff
for EcdI). Protein concentration was determined via by UV absorbance at λ=280 nm.
ATP-[32P]PPi Exchange Assays
A typical reaction mixture (500 μL) contained 1.0 μM EcdA, 2 mM amino acid substrate
(unless specified), 5 mM ATP, 10 mM MgCl2, 5 mM Na[32P]-pyrophosphate (PPi) (~1.8 ×
106 cpm/mL), and 50 mM Tris-HCl (pH 8). Mixtures were incubated at ambient temperature
for regular time intervals (e.g., 5 min), and 150 μL aliquots were removed and quenched
with 500 μL of a charcoal suspension (100 mM NaPPi, 350 mM HClO4, and 16 g/L
charcoal). The mixtures were vortexed and centrifuged at 13000 rpm for 3 min. Pellets were
washed twice with 500 μL of wash solution (100 mM NaPPi and 350 mM HClO4). Each
pellet was resuspended in 500 μL wash solution and added to 10 mL Ultima Gold
scintillation fluid. Charcoal-bound radio-activity was measured using a Beckman LS 6500
scintillation counter.
Loading of [14C]-substrate onto NRPS
The assay was carried out in two steps. First, a 50 μL reaction containing 10 μM EcdA-M1,
20 μM Sfp, 1mM CoA, 10 mM MgCl2, 1 mM TCEP, and 50 mM HEPES (pH 7.0) was
incubated at ambient temperature for 30 min to convert apo EcdA-M1 to its holoform.
Afterwards, 8 μM EcdI, 5 mM ATP, and ~ 40 μM [14C]-substrate (~ 4.4 × 106 cpm/mL)
were added and incubated for 30 min. The reaction was quenched by 600 μL acetonitrile for
the assays with [14C]-acyl substrate or 600 μL 10% trichloroacetic acid for [14C]-L-
ornithine with addition of 100μL of 1 mg/mL BSA. The mixture was vortexed and
centrifuged at 13,000 rpm for 3 min. The pellet was then washed twice with 600 μL
acetonitrile, dissolved in 250 μL formic acid, added into 10 mL Ultima Gold scintillation
fluid and subjected to a Beckman LS 6500 scintillation counter.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Identification of the ecd gene cluster. A) Organization of the ecd gene cluster. ecdA encodes
for the six-module nonribosomal peptide synthetase. ecdI encodes for the linoleyl-AMP
ligase responsible for lipo-initiation of EcdA. Also found in the cluster are ecdG, ecdH, and
ecdK encoding for proposed hydroxylases; B) Metabolic profile of ΔecdA mutant shows the
loss of production of 1.
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ATP-[32P]-PPi exchange assay of EcdA-M1 A) The adenylation (A) domain of EcdA-M1
shows preference towards L-ornithine B) Michaelis-Menten plot for the A domain of EcdA-
M1 with L-ornithine as substrate. C) Michaelis-Menten plot for the A domain of EcdA-M1
with 4(R/S)-OH-L-ornithine as substrate.
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Loading Assay of EcdA-M1. A) EcdA-M1, converted to holo form in vitro by Sfp, is loaded
with 14C-linoleic acid only in the presence of the fatty-acyl-AMP ligase EcdI and ATP as
shown in the autoradiogram (lane 5). Loading of EcdA-M1 variants with 14C-linoleic acid in
the same condition as sample 5 B) Quantification of percentage of EcdA-M1 loaded with
radioactive linoleic acid. Samples 1–7 carried out in identical conditions as in A. C) Linoleic
acid is activated by EcdI to form linoleyl-AMP which is subsequently transferred to EcdA-
M1.
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Biosynthesis of L-homotyrosine. A) Organization of hty gene cluster B) Disruption of htyA
led to the loss of production of 1, which was restored upon addition of L-homotyrosine to
the culture. C) Putative biosynthesis of L-homotyrosine.
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Echinocandin B 1 and its semisynthetic derivatives cilofungin 2 and anidulafungin 3. Also
shown are the related natural compound Pneumocandin A0 4 and its semisynthetic
derivatives caspofungin 5 and micafungin 6.
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Putative biosynthetic pathway of Echinocandin B 1
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Table 1
The Echinocandin B Biosynthetic Gene Cluster.
Gene Length (aa) Conserved Domain/Function Nearest BLAST hit (Identity, Similarity)
ecdB 545 fungal transcription factor A. fumigatus AFUA_048990 (72%, 80%)
ecdC 556 transporter (MFS) N. fischeri NFIA_042010 (70%, 79%),
ecdD 541 transporter (MFS) N. fischeri NFIA_042010 (87%, 93%)
ecdE 703 glycosyl hydrolase N. fischeri NFIA_042050 (78%, 88%)
ecdF 508 glycosidase P. purpurogenum BAA12320 (71%, 84%)
ecdA 7260 NRPS (T-C-A-T-C-A-T-C-A-T-C-A-T-C-A-T-C-A-T-C) T. reesei EGR45389(33%, 52%)
ecdG 338 non-heme iron, α-ketoglutarate dependent dioxygenase C. militaris CCM_03049 (31%, 50%),
ecdH 503 cytochrome P450 heme-iron-dependent oxygenase N. haematococca 100691 (28%, 48%),
ecdI 559 fatty-acyl- AMP ligase A. nidulans A4, AN3490 (52%, 67%),
ecdJ 668 hypothetical protein A. capsulatus 05345 (34%, 47%),
ecdK 332 non-heme iron, α-ketoglutarate dependent dioxygenase T. reesei TRIREDRAFT_58580 (43%, 63%)
ecdL 1479 multidrug transporter (ABC) M. anisoplae MAA_01638 (40%, 59%)
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Table 2
Genes found within the hty cluster
Gene Length (aa) Conserved Domain/Function Nearest BLAST hit (Identity, Similarity)
htyF 683 heme-dependent P450 oxygenase T. stipitatus TSTA_09270 (45%, 64%)
htyE 329 non-heme iron, α-ketoglutarate dependent dioxygenase A. terreus ATEG09098 (50%, 66%),
htyA 584 isopropyl malate synthase A. alternata BAI44742 (51%, 68%)
htyB 379 transaminase A. alternata BAI44740 (55%, 71%),
htyC 366 isopropyl malate dehydrogenase A. alternata BAI44741 (63%, 73%)
htyD 877 aconitase A. alternata BAI44743 (57%, 68%),
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